ArticleJournal of cellular and molecular medicine2025

TPD52 as a Therapeutic Target Identified by Machine Learning Shapes the Immune Microenvironment in Breast Cancer.

Jie Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.